Literature DB >> 11708544

Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage.

G J Pyne1, T A Cadoux-Hudson, J F Clark.   

Abstract

Mg2+ has recently been proposed for the treatment of cerebral vasospasm and is known to dilate vessels. In this study, we examine the effects of Mg2+ on in vitro vasospasm using CSF from vasospastic subarachnoid haemorrhage patients with vasospasm (CSFv). Oxygen consumption and isometric force measurements in the porcine carotid artery were used to assess the contractile and metabolic status of the vessels' responses to CSFv and the effect of Mg2+. Mg2+ caused a dose dependant decrease in tension following contraction by CSFv. Mg2+ (12 mM) caused a normalization of relaxation rate in tissue exposed to CSFv, caused a significant decrease in basal oxygen consumption, as well as significantly decreasing the rate of oxygen consumption of the porcine carotid artery when stimulated by CSF (0.70 +/- 0.12 versus. 0.46 +/- 0.1 micromol O2 min(-1) g(-1)). Acute Mg2+ addition demonstrated the most effective protection using an assay based on CSFv contraction. These results suggest that Mg2+ can protect vascular smooth muscle exposed to CSFv by benefiting contractile behaviour and metabolism of the arteries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708544     DOI: 10.1080/02688690120082413

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  13 in total

1.  The importance of magnesium in critically ill patients: a role in mitigating neurological injury and in the prevention of vasospasms.

Authors:  Kees H Polderman; Arthur R H van Zanten; Armand R J Girbes
Journal:  Intensive Care Med       Date:  2003-05-24       Impact factor: 17.440

Review 2.  Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 3.  Magnesium neuroprotection is limited in humans with acute brain injury.

Authors:  J Andrew McKee; Randall P Brewer; Gary E Macy; Cecil O Borel; James D Reynolds; David S Warner
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 4.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

5.  Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage.

Authors:  Maria Barile; Françoise van De Wyngaert; Jean-Jacques Essama Mbia; Mijael Jativa; Cécile Grandin; Herbert Rooijakkers; Philippe Hantson
Journal:  Intensive Care Med       Date:  2003-04-16       Impact factor: 17.440

6.  Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.

Authors:  Qaisar A Shah; Muhammad Zeeshan Memon; M Fareed K Suri; Gustavo J Rodriguez; Osman S Kozak; Robert A Taylor; Ramachandra P Tummala; Gabriela Vazquez; Alexandros L Georgiadis; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2009-04-16       Impact factor: 3.210

7.  Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat.

Authors:  Kentaro Mori; Masahiro Miyazaki; Junko Iwata; Takuji Yamamoto; Yasuaki Nakao
Journal:  Neurosurg Rev       Date:  2008-02-06       Impact factor: 3.042

8.  Dexanabinol prevents development of vasospasm in the rat femoral artery model.

Authors:  Ramazan Durmaz; Ahmet Ozsandik; Varol Sahintürk; Kismet Civi; Cengiz Bayçu; Hilmi Ozden; Amselem Shimon
Journal:  Neurosurg Rev       Date:  2008-02-07       Impact factor: 3.042

Review 9.  Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome.

Authors:  Joseph R Geraghty; Joseph L Davis; Fernando D Testai
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

10.  The role of magnesium in the management of cerebral vasospasm.

Authors:  Mitchell J Odom; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.